News

Investing Snacks1d
Mufg Makes a Micro Move, but Regeneron Feels It
Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...
WTEN Albany on MSN1d
Regeneron buying 23andMe
Regeneron buying 23andMe ...
Scripps News on MSN1d
Biotechnology company Regeneron buying 23andMe for $256 million
Regeneron said Monday that it will comply with 23andMe's privacy policies and applicable law. (Scripps News) Maryland ...
23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private
Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as ...
23andMe, Inc.: Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
Regeneron Commits to Comply with Company's Privacy Policy and All Applicable Law; No Changes to 23andMe's Privacy Policy or Consumer Genome Services Transaction Subject to Court Approval SAN FRANCISCO ...
Regeneron to buy 23andMe for $256M in court-supervised sale
Regeneron Pharmaceuticals (NASDAQ:REGN) will buy substantially all assets of genetic testing firm 23andMe for a purchase pric ...
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
This was the stock's second consecutive day of gains.
Regeneron upgraded, AbbVie downgraded as Citi reviews policy risk
Regeneron (REGN) stock was upgraded to Buy and AbbVie (ABBV) stock was downgraded at Citi based on policy risks under Trump's drug reforms. Read more here.